These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 8827358

  • 1. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
    Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller R, Franz C, Kahle L, Campbell WS, Tangrea JA, Schatzkin A.
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):533-9. PubMed ID: 8827358
    [Abstract] [Full Text] [Related]

  • 2. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E.
    J Natl Cancer Inst; 2005 May 18; 97(10):755-65. PubMed ID: 15900045
    [Abstract] [Full Text] [Related]

  • 3. Serum sex hormones and breast cancer risk factors in postmenopausal women.
    Lamar CA, Dorgan JF, Longcope C, Stanczyk FZ, Falk RT, Stephenson HE.
    Cancer Epidemiol Biomarkers Prev; 2003 Apr 18; 12(4):380-3. PubMed ID: 12692114
    [Abstract] [Full Text] [Related]

  • 4. Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.
    Schairer C, Hill D, Sturgeon SR, Fears T, Mies C, Ziegler RG, Hoover RN, Sherman ME.
    Cancer Epidemiol Biomarkers Prev; 2005 Jul 18; 14(7):1660-5. PubMed ID: 16030098
    [Abstract] [Full Text] [Related]

  • 5. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
    Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT, Allen NE, Bueno-de-Mesquita HB, van Gils CH, Grobbee D, Boeing H, Lahmann PH, Nagel G, Chang-Claude J, Clavel-Chapelon F, Fournier A, Thiébaut A, González CA, Quirós JR, Tormo MJ, Ardanaz E, Amiano P, Krogh V, Palli D, Panico S, Tumino R, Vineis P, Trichopoulou A, Kalapothaki V, Trichopoulos D, Ferrari P, Norat T, Saracci R, Riboli E.
    Endocr Relat Cancer; 2005 Dec 18; 12(4):1071-82. PubMed ID: 16322344
    [Abstract] [Full Text] [Related]

  • 6. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.
    J Natl Cancer Inst; 2004 Dec 15; 96(24):1856-65. PubMed ID: 15601642
    [Abstract] [Full Text] [Related]

  • 7. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.
    J Natl Cancer Inst; 2006 Oct 04; 98(19):1406-15. PubMed ID: 17018787
    [Abstract] [Full Text] [Related]

  • 8. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
    Dorgan JF, Stanczyk FZ, Longcope C, Stephenson HE, Chang L, Miller R, Franz C, Falk RT, Kahle L.
    Cancer Epidemiol Biomarkers Prev; 1997 Mar 04; 6(3):177-81. PubMed ID: 9138660
    [Abstract] [Full Text] [Related]

  • 9. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):595-602. PubMed ID: 15840882
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA, Borofsky ND, Massardo S, Orentreich N.
    Cancer Epidemiol Biomarkers Prev; 2002 Dec 20; 11(12):1566-73. PubMed ID: 12496045
    [Abstract] [Full Text] [Related]

  • 11. Sources of elevated serum androgens in postmenopausal women who develop breast cancer.
    Dorgan JF, Boudou P, Stanczyk FZ, Longcope C, Tejpar AA, Falk RT, Schussler N, Stephenson HE.
    Cancer Epidemiol Biomarkers Prev; 2001 Apr 20; 10(4):407-10. PubMed ID: 11319184
    [Abstract] [Full Text] [Related]

  • 12. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Chen C, Weiss NS, Stanczyk FZ, Lewis SK, DiTommaso D, Etzioni R, Barnett MJ, Goodman GE.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 20; 12(12):1410-6. PubMed ID: 14693730
    [Abstract] [Full Text] [Related]

  • 13. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):110-5. PubMed ID: 16418513
    [Abstract] [Full Text] [Related]

  • 14. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women.
    Baglietto L, Severi G, English DR, Krishnan K, Hopper JL, McLean C, Morris HA, Tilley WD, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2010 Feb 18; 19(2):492-502. PubMed ID: 20086116
    [Abstract] [Full Text] [Related]

  • 15. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
    Tworoger SS, Eliassen AH, Sluss P, Hankinson SE.
    J Clin Oncol; 2007 Apr 20; 25(12):1482-8. PubMed ID: 17372279
    [Abstract] [Full Text] [Related]

  • 16. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
    Yu H, Shu XO, Li BD, Dai Q, Gao YT, Jin F, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2003 Oct 20; 12(10):1067-73. PubMed ID: 14578144
    [Abstract] [Full Text] [Related]

  • 17. Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.
    Arslan AA, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Lukanova A, Afanasyeva Y, Lenner P, Krogh V, Muti P, Rinaldi S, Kaaks R, Berrino F, Hallmans G, Toniolo P.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 20; 12(12):1531-5. PubMed ID: 14693749
    [Abstract] [Full Text] [Related]

  • 18. Fasting glucose is a risk factor for breast cancer: a prospective study.
    Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schünemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov 20; 11(11):1361-8. PubMed ID: 12433712
    [Abstract] [Full Text] [Related]

  • 19. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.
    Vatten LJ, Holly JM, Gunnell D, Tretli S.
    Cancer Epidemiol Biomarkers Prev; 2008 Aug 20; 17(8):2097-100. PubMed ID: 18708402
    [Abstract] [Full Text] [Related]

  • 20. Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values.
    Endogenous Hormones and Breast Cancer Collaborative Group.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 20; 12(12):1457-61. PubMed ID: 14693737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.